It has recently been suggested that the role of TGF‐β inhibitors in cancer function primarily by targeting the tumor microenvironment as TGF‐β inhibitors have demonstrated minimal effect on cancer cell proliferation in vitro. The gene discussed is TGFB1; the disease is neoplasm.